title: Final hearings begin in epic legal battle over Novartis drug in India.
authors.forename: Ganapati
authors.initials: G
authors.lastname: Mudur
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics; D001549:Benzamides; D016568:Drugs, Generic / Q000191:economics; D005252:Fees, Pharmaceutical; D006801:Humans; D000068877:Imatinib Mesylate; D007194:India; D007880:Legislation, Drug / Q000191:economics*; D010330:Patents as Topic / Q000331:legislation & jurisprudence; D010879:Piperazines / Q000191:economics*; D011743:Pyrimidines / Q000191:economics*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D016568:Drugs, Generic; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate